15/11/2024  08:16:23 Chg. -7.45 Volume Bid20:59:42 Demandez à20:59:42 Capitalisation boursière Dividende Y. Rapport P/E
226.85EUR -3.18% 0
Chiffrre d'affaires: 0.00
226.90Bid taille: 140 227.65Ask la taille: 140 44.97 Mrd.EUR - -

Description de l'entreprise

Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
 

Conseil d'administration & Conseil de surveillance

PDG
Steven H. Collis
Conseil d'administration
James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas
Conseil de surveillance
Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D.
 

Données de l'entreprise

Nom: Cencora Inc
Adresse: 1 West First Avenue,Conshohocken, PA 19428-1800, USA
Téléphone: +1-610-727-7000
Fax: +1-800-640-5221
Courriel: InvestorRelations@cencora.com
Internet: https://www.cencora.com/
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 30/09
Flotte libre: 55.10%
IPO date: 04/04/1995

Relations avec les investisseurs

Nom: Bennett Murphy
Téléphone IR: +1-610-727-3693
IR-Fax: -
E-mail IR: bennett.murphy@cencora.com

Calendrier de l'entreprise

CW 48 | 29/11/2024 Dividend Payment
 

Principaux actionnaires

Autres
 
58.24%
Vanguard Group
 
10.28%
BlackRock Inc.
 
9.86%
PRICE T ROWE ASSOCIATES INC MD
 
5.36%
State Street Corporation
 
3.95%
JP Morgan Chase & Co.
 
2.73%
FMR LLC.
 
2.31%
Boston Partners
 
2.02%
Wellington Management Group
 
1.90%
Autres
 
3.35%